Before propensity score matching, sex, gross type, tumor differentiation, histopathology, cT and cN stages, serum CEA level, serum CA199 level, ASA, and BMI were not significantly different between the groups (Table 1). The gene discussed is CEACAM5; the disease is neoplasm.